Drug
Paliperidone
Paliperidone: highest development phase Post-Market, developed by Johnson & Johnson. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| Paliperidone ER NCT00757705 | Post-Market | Schizophrenia |
| Paliperidone ER NCT00077714 | Phase 3 | Schizophrenia |
| paliperidone ER NCT01060228 | Phase 1 | Schizophrenia |
Latest
No recent events.
Follow Paliperidone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.